MyFinsight
Home
About
Contact
arct: the income statement
Download
Download image
Comprehensive loss
-$13,448K
(-94.81%↓ Y/Y)
Net loss
-$13,448K
(-94.81%↓ Y/Y)
Gates Foundation
$1,103K
Biomedical Advanced
Research And Development...
$1,895K
Other
$600K
Csl Seqirus
$13,553K
Net loss before
income taxes
-$13,448K
(-88.88%↓ Y/Y)
Finance income, net
$3,234K
(-15.30%↓ Y/Y)
Grant
$2,998K
Collaboration Revenue
$14,153K
Loss from foreign
currency
-$170K
(15.42%↑ Y/Y)
Loss from operations
-$16,512K
(-53.79%↓ Y/Y)
Total revenue
$17,151K
(-58.84%↓ Y/Y)
Total operating
expenses
$33,663K
(-35.77%↓ Y/Y)
General and
administrative
$10,398K
(-21.68%↓ Y/Y)
Research and
development, net
$23,265K
(-40.55%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Arcturus Therapeutics Holdings Inc. (ARCT)
Arcturus Therapeutics Holdings Inc. (ARCT)